These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10533486)

  • 21. Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units.
    Hidalgo M; Izbicka E; Eckhardt SG; MacDonald JR; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Oct; 10(9):837-44. PubMed ID: 10587294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
    Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
    J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of temozolomide against human tumor colony-forming units.
    Raymond E; Izbicka E; Soda H; Gerson SL; Dugan M; Von Hoff DD
    Clin Cancer Res; 1997 Oct; 3(10):1769-74. PubMed ID: 9815562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
    Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antineoplastic activity of CNC-cysteamine and related compounds.
    Tang WC; Schmid J; Fiebig HH; Eisenbrand G
    J Cancer Res Clin Oncol; 1986; 111(1):25-30. PubMed ID: 3949847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and cytotoxic properties of the isomeric forms of N,N'-bis[N-2-chloroethyl)-N-nitrosocarbamoyl] cystamine.
    Farhi JJ; Bennoun M; Tapiero H; Wang AL; Tew KD
    Biochem Pharmacol; 1984 Aug; 33(16):2575-80. PubMed ID: 6466373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased erythroid colony-forming cell response of XTfm/Y mice to testosterone and 5 beta-dihydrotestosterone.
    Beckman B; Fisher JW
    Endocrinology; 1980 Nov; 107(5):1587-92. PubMed ID: 7428682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In the search for new anticancer drugs. 27. Synthesis and comparison of anticancer activity in vivo of amino acids, carbohydrates, and carbohydrate-amino acid conjugates containing the [N'-(2-chloroethyl)-N'-nitrosoamino]carbonyl group.
    Sosnovsky G; Gnewuch CT
    J Pharm Sci; 1994 Jul; 83(7):989-98. PubMed ID: 7965679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.
    Burris HA; Hanauske AR; Johnson RK; Marshall MH; Kuhn JG; Hilsenbeck SG; Von Hoff DD
    J Natl Cancer Inst; 1992 Dec; 84(23):1816-20. PubMed ID: 1331485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells.
    Depenbrock H; Peter R; Faircloth GT; Manzanares I; Jimeno J; Hanauske AR
    Br J Cancer; 1998 Sep; 78(6):739-44. PubMed ID: 9743292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
    Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In the search for new anticancer drugs. 28. Synthesis and evaluation of highly active aminoxyl labeled amino acid derivatives containing the [N'-(2-chloroethyl)-N'-nitrosoamino]carbonyl group.
    Sosnovsky G; Baysal M; Erciyas E
    J Pharm Sci; 1994 Jul; 83(7):999-1005. PubMed ID: 7965680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.
    Lazarus P; Dufour M; Isabel G; Panasci LC
    Cancer Chemother Pharmacol; 1986; 16(2):148-52. PubMed ID: 3948300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
    Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
    Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative activity of Titanocene Y against tumor colony-forming units.
    Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE; Sherry B; Cooper S; Ruscetti FW; Williams DE; Arosio P; Kwon BS; Cerami A
    J Immunol; 1991 Oct; 147(8):2586-94. PubMed ID: 1918979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Schein PS; Bull JM; Doukas D; Hoth D
    Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro.
    Depenbrock H; Wenger M; Peter R; Fellbaum C; Block T; Rastetter J; Hanauske AR
    Invest New Drugs; 1995; 13(2):117-23. PubMed ID: 8617573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro.
    Eckardt JR; Burris HA; Kuhn JG; Bissery MC; Klink-Alakl M; Clark GM; Von Hoff DD
    J Natl Cancer Inst; 1994 Jan; 86(1):30-3. PubMed ID: 8271279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.